Trial Profile
A Phase I, Open-label, Randomized, Cross-over Trial to Investigate the Relative Bioavailability of Two Tepotinib Film-Coated Tablet Formulations in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Feb 2019
Price :
$35
*
At a glance
- Drugs Tepotinib (Primary)
- Indications Liver cancer; Non-small cell lung cancer; Solid tumours
- Focus Pharmacokinetics
- Sponsors Merck KGaA
- 02 Feb 2016 New trial record